UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS. James Hawkins 16/01/2026 James Hawkins 16/01/2026 The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures Read More James Hawkins 16/01/2026 James Hawkins 16/01/2026 An open-label pilot study of psilocybin-assisted therapy for binge eating disorder Read More James Hawkins 16/01/2026 James Hawkins 16/01/2026 The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences Read More James Hawkins 16/01/2026 James Hawkins 16/01/2026 Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial Read More James Hawkins 08/01/2026 James Hawkins 08/01/2026 Psychedelics: The pathway to implementation in the European healthcare systems Read More James Hawkins 08/01/2026 James Hawkins 08/01/2026 The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice Read More James Hawkins 08/01/2026 James Hawkins 08/01/2026 Exploring the effects of microdosing on health behaviour change Read More James Hawkins 27/12/2025 James Hawkins 27/12/2025 Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial Read More James Hawkins 22/12/2025 James Hawkins 22/12/2025 A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness Read More James Hawkins 20/12/2025 James Hawkins 20/12/2025 MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial Read More James Hawkins 20/12/2025 James Hawkins 20/12/2025 Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study Read More James Hawkins 20/12/2025 James Hawkins 20/12/2025 Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans Read More James Hawkins 13/12/2025 James Hawkins 13/12/2025 Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity Read More James Hawkins 12/12/2025 James Hawkins 12/12/2025 Psychedelic ‘Ego Death’ with DMT May be Tied to a Collapse in Alpha Brain Waves Read More James Hawkins 10/12/2025 James Hawkins 10/12/2025 MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial Read More James Hawkins 10/12/2025 James Hawkins 10/12/2025 Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial Read More James Hawkins 04/12/2025 James Hawkins 04/12/2025 Exploring practitioners’ perceptions of health behavior changes associated with psychedelic experiences Read More James Hawkins 03/12/2025 James Hawkins 03/12/2025 Psychedelics may enhance emotional closeness and relationship satisfaction when used therapeutically Read More James Hawkins 01/12/2025 James Hawkins 01/12/2025 5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA Read More James Hawkins 01/12/2025 James Hawkins 01/12/2025 Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports Read More Older Posts
James Hawkins 16/01/2026 James Hawkins 16/01/2026 The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures Read More
James Hawkins 16/01/2026 James Hawkins 16/01/2026 An open-label pilot study of psilocybin-assisted therapy for binge eating disorder Read More
James Hawkins 16/01/2026 James Hawkins 16/01/2026 The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences Read More
James Hawkins 16/01/2026 James Hawkins 16/01/2026 Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial Read More
James Hawkins 08/01/2026 James Hawkins 08/01/2026 Psychedelics: The pathway to implementation in the European healthcare systems Read More
James Hawkins 08/01/2026 James Hawkins 08/01/2026 The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice Read More
James Hawkins 08/01/2026 James Hawkins 08/01/2026 Exploring the effects of microdosing on health behaviour change Read More
James Hawkins 27/12/2025 James Hawkins 27/12/2025 Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial Read More
James Hawkins 22/12/2025 James Hawkins 22/12/2025 A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness Read More
James Hawkins 20/12/2025 James Hawkins 20/12/2025 MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial Read More
James Hawkins 20/12/2025 James Hawkins 20/12/2025 Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study Read More
James Hawkins 20/12/2025 James Hawkins 20/12/2025 Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans Read More
James Hawkins 13/12/2025 James Hawkins 13/12/2025 Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity Read More
James Hawkins 12/12/2025 James Hawkins 12/12/2025 Psychedelic ‘Ego Death’ with DMT May be Tied to a Collapse in Alpha Brain Waves Read More
James Hawkins 10/12/2025 James Hawkins 10/12/2025 MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial Read More
James Hawkins 10/12/2025 James Hawkins 10/12/2025 Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial Read More
James Hawkins 04/12/2025 James Hawkins 04/12/2025 Exploring practitioners’ perceptions of health behavior changes associated with psychedelic experiences Read More
James Hawkins 03/12/2025 James Hawkins 03/12/2025 Psychedelics may enhance emotional closeness and relationship satisfaction when used therapeutically Read More
James Hawkins 01/12/2025 James Hawkins 01/12/2025 5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA Read More
James Hawkins 01/12/2025 James Hawkins 01/12/2025 Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports Read More
